Realm Therapeutics Plc (RLM)

Realm Therapeutics Plc, a biopharmaceutical company, focuses on developing therapies for the treatment of immune-mediated diseases in adults and children. Its product pipeline includes PRO22, a topical gel, which is conducting initial Phase II clinical studies for the treatment of atopic dermatitis. The company was formerly known as PuriCore plc and changed its name to Realm Therapeutics Plc in December 2016. Realm Therapeutics Plc is based in London, the United Kingdom.

Current Quote*
Last: $2.338
Change: 0.012
Book: $Unk
Volume: 4,836

As Of: 01/18 13:34 ET
*Quotes delayed by 20min.

Graphs for RLM

3 Month Graph

6 Month Graph

1 Year Graph